Doshi Dipal bought TRDA
March 1, 2026 · Form 4 insider transaction
Doshi Dipal bought 208,000 shares of Entrada Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
208,000
Price
$0.00
Total value
N/A
InsiderDoshi Dipal
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after208,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the option shares shall vest and become exercisable on March 1, 2027, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, such that the option shares will be fully vested on March 1, 2030.